Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients: A case series and systematic literature review

Chiara Robba, Andrea Ortu, Federico Bilotta, Alessandra Lombardo, Mypinder S. Sekhon, Fabio Gallo, Basil F. Matta

Research output: Contribution to journalReview article

Abstract

BACKGROUND: Venovenous extracorporeal membrane oxygenation (vv-ECMO) is an established salvage therapy for severe respiratory failure, and may provide an alternative form of treatment for trauma-induced adult respiratory distress syndrome (ARDS) when conventional treatments have failed. The need for systemic anticoagulation is a relative contraindication for patients with bleeding risks, especially in multitraumatic injury. METHODS: We describe a case series of four trauma patients with ARDS who were managed with ECMO admitted to the neuro critical care unit at Addenbrooke's Hospital, Cambridge (UK), from January 2000 to January 2016.We performed a systematic review of the available literature to investigate the safety and efficacy of vv-ECMO in posttraumatic ARDS, focusing on the use of different anticoagulation strategies and risk of bleeding on patients with multiple injuries. RESULTS: Thirty-one patients were included. A heparin bolus was given in 16 cases. Eleven patients developed complications during treatment with ECMO with three cases of major bleeding. In all documented cases of bleeding a bolus and infusion of heparin was administered, aiming for an activated clotting time (ACT) target longer than 150 seconds. Two patients treated with heparin-free ECMO developed thromboembolic complications. Four patients died, and death was never directly or indirectly related to use of ECMO. CONCLUSION: vv-ECMO can be lifesaving in respiratory failure. Our experience and our literature review suggest that vv-ECMOshould be considered as a rescue treatment for the management of severe hypoxemic respiratory failure secondary to ARDS in trauma patients. For patients with a high risk of bleeding, the use of ECMO with no initial anticoagulation could be considered a valid option. For patients with a moderate risk of bleeding, use of a heparin infusion keeping an ACT target shorter than 150 seconds can be appropriate. (J Trauma Acute Care Surg. 2017;82: 165-173.

Original languageEnglish
Pages (from-to)165-173
Number of pages9
JournalJournal of Trauma and Acute Care Surgery
Volume82
Issue number1
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Adult Respiratory Distress Syndrome
Wounds and Injuries
Hemorrhage
Heparin
Respiratory Insufficiency
Salvage Therapy
Multiple Trauma
Critical Care
Therapeutics
Safety

Keywords

  • Adult respiratory distress syndrome
  • Extracorporeal membrane oxygenation
  • Hypoxemic respiratory failure
  • Trauma

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients : A case series and systematic literature review. / Robba, Chiara; Ortu, Andrea; Bilotta, Federico; Lombardo, Alessandra; Sekhon, Mypinder S.; Gallo, Fabio; Matta, Basil F.

In: Journal of Trauma and Acute Care Surgery, Vol. 82, No. 1, 2017, p. 165-173.

Research output: Contribution to journalReview article

Robba, Chiara ; Ortu, Andrea ; Bilotta, Federico ; Lombardo, Alessandra ; Sekhon, Mypinder S. ; Gallo, Fabio ; Matta, Basil F. / Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients : A case series and systematic literature review. In: Journal of Trauma and Acute Care Surgery. 2017 ; Vol. 82, No. 1. pp. 165-173.
@article{4e2074a9a18b4d269992f9e300abc3df,
title = "Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients: A case series and systematic literature review",
abstract = "BACKGROUND: Venovenous extracorporeal membrane oxygenation (vv-ECMO) is an established salvage therapy for severe respiratory failure, and may provide an alternative form of treatment for trauma-induced adult respiratory distress syndrome (ARDS) when conventional treatments have failed. The need for systemic anticoagulation is a relative contraindication for patients with bleeding risks, especially in multitraumatic injury. METHODS: We describe a case series of four trauma patients with ARDS who were managed with ECMO admitted to the neuro critical care unit at Addenbrooke's Hospital, Cambridge (UK), from January 2000 to January 2016.We performed a systematic review of the available literature to investigate the safety and efficacy of vv-ECMO in posttraumatic ARDS, focusing on the use of different anticoagulation strategies and risk of bleeding on patients with multiple injuries. RESULTS: Thirty-one patients were included. A heparin bolus was given in 16 cases. Eleven patients developed complications during treatment with ECMO with three cases of major bleeding. In all documented cases of bleeding a bolus and infusion of heparin was administered, aiming for an activated clotting time (ACT) target longer than 150 seconds. Two patients treated with heparin-free ECMO developed thromboembolic complications. Four patients died, and death was never directly or indirectly related to use of ECMO. CONCLUSION: vv-ECMO can be lifesaving in respiratory failure. Our experience and our literature review suggest that vv-ECMOshould be considered as a rescue treatment for the management of severe hypoxemic respiratory failure secondary to ARDS in trauma patients. For patients with a high risk of bleeding, the use of ECMO with no initial anticoagulation could be considered a valid option. For patients with a moderate risk of bleeding, use of a heparin infusion keeping an ACT target shorter than 150 seconds can be appropriate. (J Trauma Acute Care Surg. 2017;82: 165-173.",
keywords = "Adult respiratory distress syndrome, Extracorporeal membrane oxygenation, Hypoxemic respiratory failure, Trauma",
author = "Chiara Robba and Andrea Ortu and Federico Bilotta and Alessandra Lombardo and Sekhon, {Mypinder S.} and Fabio Gallo and Matta, {Basil F.}",
year = "2017",
doi = "10.1097/TA.0000000000001276",
language = "English",
volume = "82",
pages = "165--173",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients

T2 - A case series and systematic literature review

AU - Robba, Chiara

AU - Ortu, Andrea

AU - Bilotta, Federico

AU - Lombardo, Alessandra

AU - Sekhon, Mypinder S.

AU - Gallo, Fabio

AU - Matta, Basil F.

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Venovenous extracorporeal membrane oxygenation (vv-ECMO) is an established salvage therapy for severe respiratory failure, and may provide an alternative form of treatment for trauma-induced adult respiratory distress syndrome (ARDS) when conventional treatments have failed. The need for systemic anticoagulation is a relative contraindication for patients with bleeding risks, especially in multitraumatic injury. METHODS: We describe a case series of four trauma patients with ARDS who were managed with ECMO admitted to the neuro critical care unit at Addenbrooke's Hospital, Cambridge (UK), from January 2000 to January 2016.We performed a systematic review of the available literature to investigate the safety and efficacy of vv-ECMO in posttraumatic ARDS, focusing on the use of different anticoagulation strategies and risk of bleeding on patients with multiple injuries. RESULTS: Thirty-one patients were included. A heparin bolus was given in 16 cases. Eleven patients developed complications during treatment with ECMO with three cases of major bleeding. In all documented cases of bleeding a bolus and infusion of heparin was administered, aiming for an activated clotting time (ACT) target longer than 150 seconds. Two patients treated with heparin-free ECMO developed thromboembolic complications. Four patients died, and death was never directly or indirectly related to use of ECMO. CONCLUSION: vv-ECMO can be lifesaving in respiratory failure. Our experience and our literature review suggest that vv-ECMOshould be considered as a rescue treatment for the management of severe hypoxemic respiratory failure secondary to ARDS in trauma patients. For patients with a high risk of bleeding, the use of ECMO with no initial anticoagulation could be considered a valid option. For patients with a moderate risk of bleeding, use of a heparin infusion keeping an ACT target shorter than 150 seconds can be appropriate. (J Trauma Acute Care Surg. 2017;82: 165-173.

AB - BACKGROUND: Venovenous extracorporeal membrane oxygenation (vv-ECMO) is an established salvage therapy for severe respiratory failure, and may provide an alternative form of treatment for trauma-induced adult respiratory distress syndrome (ARDS) when conventional treatments have failed. The need for systemic anticoagulation is a relative contraindication for patients with bleeding risks, especially in multitraumatic injury. METHODS: We describe a case series of four trauma patients with ARDS who were managed with ECMO admitted to the neuro critical care unit at Addenbrooke's Hospital, Cambridge (UK), from January 2000 to January 2016.We performed a systematic review of the available literature to investigate the safety and efficacy of vv-ECMO in posttraumatic ARDS, focusing on the use of different anticoagulation strategies and risk of bleeding on patients with multiple injuries. RESULTS: Thirty-one patients were included. A heparin bolus was given in 16 cases. Eleven patients developed complications during treatment with ECMO with three cases of major bleeding. In all documented cases of bleeding a bolus and infusion of heparin was administered, aiming for an activated clotting time (ACT) target longer than 150 seconds. Two patients treated with heparin-free ECMO developed thromboembolic complications. Four patients died, and death was never directly or indirectly related to use of ECMO. CONCLUSION: vv-ECMO can be lifesaving in respiratory failure. Our experience and our literature review suggest that vv-ECMOshould be considered as a rescue treatment for the management of severe hypoxemic respiratory failure secondary to ARDS in trauma patients. For patients with a high risk of bleeding, the use of ECMO with no initial anticoagulation could be considered a valid option. For patients with a moderate risk of bleeding, use of a heparin infusion keeping an ACT target shorter than 150 seconds can be appropriate. (J Trauma Acute Care Surg. 2017;82: 165-173.

KW - Adult respiratory distress syndrome

KW - Extracorporeal membrane oxygenation

KW - Hypoxemic respiratory failure

KW - Trauma

UR - http://www.scopus.com/inward/record.url?scp=84992390399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992390399&partnerID=8YFLogxK

U2 - 10.1097/TA.0000000000001276

DO - 10.1097/TA.0000000000001276

M3 - Review article

C2 - 27779577

AN - SCOPUS:84992390399

VL - 82

SP - 165

EP - 173

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 1

ER -